Massive study launches to track Real-World bipolar treatment
NCT ID NCT07263191
Summary
This study aims to observe and understand how olanzapine is used to treat bipolar disorder in real-world settings. It will follow 3,000 patients to see what other treatments they receive and if providing education about weight gain, a common side effect, helps prevent it. The goal is to gather knowledge to improve future care, not to test a new treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BIPOLAR DISORDER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
CHA Bundang Medical Center
RECRUITINGSeongnam, South Korea
Contact
Conditions
Explore the condition pages connected to this study.